Showing 1086 results
-
Press release /Ociperlimab adds innovative and complementary late-stage TIGIT inhibitor to an Oncology portfolio poised for growth Two Phase III trials underway in non-small cell lung cancer and additional studies…
-
Story /Novartis data scientists are using super-resolution microscopy to see neurodegeneration the moment it starts.
-
Press release /New longer-term efficacy and safety data from pivotal Phase III ASCEMBL study for recently US-approved Scemblix® (asciminib) in patients with PH+ CML-CPEarly findings from YTB323 and PHE885 CAR-T…
-
Story /Researchers at Novartis are combining modern techniques with an old approach to drug discovery and getting surprising results.
-
Press release /Pemetrexed is indicated for patients with non-squamous Non-Small Cell Lung Cancer (NSCLC), who represent over 3 in 4 patients with lung cancer1 New ready-to-dilute format and 1,000 mg strength…
-
Press release /Eight of nine evaluable patients tested had no signs of CLL in their bone marrow at three months.CTL119 is a humanized CD19-directed CAR-T cell therapy being developed in collaboration with the…
-
Story /As part of the Beacon of Hope initiative, the Novartis Institutes for BioMedical Research (NIBR) in Cambridge, Massachusetts, US, offers 10-week paid summer fellowships for students at Historically Black Medical Schools to gain experience in drug discovery, data analytics and clinical research practices - with the goal of training up to 250 scientific leaders over 10 years.
-
Story /When a middle-aged firefighter and active Boy Scout leader in the Midwestern United States lost his hearing a few years ago, he also faced the loss of his livelihood.